nodes	percent_of_prediction	percent_of_DWPC	metapath
Bopindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00712	0.00712	CbGpPWpGaD
Bopindolol—HTR1B—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.0071	0.0071	CbGpPWpGaD
Bopindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00696	0.00696	CbGpPWpGaD
Bopindolol—HTR1B—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00696	0.00696	CbGpPWpGaD
Bopindolol—HTR1B—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.00667	0.00667	CbGpPWpGaD
Bopindolol—HTR1B—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.00667	0.00667	CbGpPWpGaD
Bopindolol—HTR1B—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00659	0.00659	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00652	0.00652	CbGpPWpGaD
Bopindolol—ADRB3—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00638	0.00638	CbGpPWpGaD
Bopindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00624	0.00624	CbGpPWpGaD
Bopindolol—HTR1B—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00619	0.00619	CbGpPWpGaD
Bopindolol—ADRB1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00613	0.00613	CbGpPWpGaD
Bopindolol—ADRB2—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00599	0.00599	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00586	0.00586	CbGpPWpGaD
Bopindolol—ADRB3—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00577	0.00577	CbGpPWpGaD
Bopindolol—ADRB3—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.0057	0.0057	CbGpPWpGaD
Bopindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00564	0.00564	CbGpPWpGaD
Bopindolol—ADRB1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00554	0.00554	CbGpPWpGaD
Bopindolol—ADRB3—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00542	0.00542	CbGpPWpGaD
Bopindolol—ADRB3—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00542	0.00542	CbGpPWpGaD
Bopindolol—ADRB2—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00542	0.00542	CbGpPWpGaD
Bopindolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00542	0.00542	CbGpPWpGaD
Bopindolol—HTR1A—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.00541	0.00541	CbGpPWpGaD
Bopindolol—HTR1A—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	0.00535	0.00535	CbGpPWpGaD
Bopindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00531	0.00531	CbGpPWpGaD
Bopindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00531	0.00531	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.0053	0.0053	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.0053	0.0053	CbGpPWpGaD
Bopindolol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00525	0.00525	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00519	0.00519	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00516	0.00516	CbGpPWpGaD
Bopindolol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00513	0.00513	CbGpPWpGaD
Bopindolol—HTR1A—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.00508	0.00508	CbGpPWpGaD
Bopindolol—HTR1A—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.00508	0.00508	CbGpPWpGaD
Bopindolol—HTR1B—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.00508	0.00508	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00508	0.00508	CbGpPWpGaD
Bopindolol—HTR1A—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00502	0.00502	CbGpPWpGaD
Bopindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00497	0.00497	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00496	0.00496	CbGpPWpGaD
Bopindolol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00493	0.00493	CbGpPWpGaD
Bopindolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00488	0.00488	CbGpPWpGaD
Bopindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00486	0.00486	CbGpPWpGaD
Bopindolol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00482	0.00482	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00479	0.00479	CbGpPWpGaD
Bopindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00475	0.00475	CbGpPWpGaD
Bopindolol—HTR1B—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00475	0.00475	CbGpPWpGaD
Bopindolol—HTR1A—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00472	0.00472	CbGpPWpGaD
Bopindolol—HTR1B—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.00457	0.00457	CbGpPWpGaD
Bopindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00449	0.00449	CbGpPWpGaD
Bopindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.0044	0.0044	CbGpPWpGaD
Bopindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.0043	0.0043	CbGpPWpGaD
Bopindolol—HTR1B—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.0043	0.0043	CbGpPWpGaD
Bopindolol—HTR1B—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00424	0.00424	CbGpPWpGaD
Bopindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00423	0.00423	CbGpPWpGaD
Bopindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00423	0.00423	CbGpPWpGaD
Bopindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00413	0.00413	CbGpPWpGaD
Bopindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00413	0.00413	CbGpPWpGaD
Bopindolol—ADRB3—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00412	0.00412	CbGpPWpGaD
Bopindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00404	0.00404	CbGpPWpGaD
Bopindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00404	0.00404	CbGpPWpGaD
Bopindolol—HTR1B—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00404	0.00404	CbGpPWpGaD
Bopindolol—HTR1B—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00404	0.00404	CbGpPWpGaD
Bopindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00404	0.00404	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00395	0.00395	CbGpPWpGaD
Bopindolol—HTR1A—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.00387	0.00387	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00385	0.00385	CbGpPWpGaD
Bopindolol—ADRB1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00378	0.00378	CbGpPWpGaD
Bopindolol—ADRB3—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00372	0.00372	CbGpPWpGaD
Bopindolol—ADRB2—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.0037	0.0037	CbGpPWpGaD
Bopindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00364	0.00364	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00362	0.00362	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00357	0.00357	CbGpPWpGaD
Bopindolol—HTR1A—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.00348	0.00348	CbGpPWpGaD
Bopindolol—ADRB1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00342	0.00342	CbGpPWpGaD
Bopindolol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00338	0.00338	CbGpPWpGaD
Bopindolol—ADRB2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00335	0.00335	CbGpPWpGaD
Bopindolol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00331	0.00331	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00327	0.00327	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00327	0.00327	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00326	0.00326	CbGpPWpGaD
Bopindolol—HTR1A—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00323	0.00323	CbGpPWpGaD
Bopindolol—ADRB1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00322	0.00322	CbGpPWpGaD
Bopindolol—ADRB1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00322	0.00322	CbGpPWpGaD
Bopindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00321	0.00321	CbGpPWpGaD
Bopindolol—ADRB2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00315	0.00315	CbGpPWpGaD
Bopindolol—ADRB2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00315	0.00315	CbGpPWpGaD
Bopindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00314	0.00314	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00314	0.00314	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00313	0.00313	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00313	0.00313	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00308	0.00308	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00308	0.00308	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00308	0.00308	CbGpPWpGaD
Bopindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00308	0.00308	CbGpPWpGaD
Bopindolol—HTR1B—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00307	0.00307	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00307	0.00307	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00306	0.00306	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00306	0.00306	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00301	0.00301	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.003	0.003	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00296	0.00296	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00293	0.00293	CbGpPWpGaD
Bopindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.0029	0.0029	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00284	0.00284	CbGpPWpGaD
Bopindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00283	0.00283	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00283	0.00283	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00278	0.00278	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00278	0.00278	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00278	0.00278	CbGpPWpGaD
Bopindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00277	0.00277	CbGpPWpGaD
Bopindolol—HTR1B—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00277	0.00277	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00272	0.00272	CbGpPWpGaD
Bopindolol—ADRB1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00245	0.00245	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00244	0.00244	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00243	0.00243	CbGpPWpGaD
Bopindolol—ADRB2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00239	0.00239	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00234	0.00234	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00233	0.00233	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00233	0.00233	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.00233	0.00233	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.0023	0.0023	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00228	0.00228	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00228	0.00228	CbGpPWpGaD
Bopindolol—ADRB1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00221	0.00221	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00221	0.00221	CbGpPWpGaD
Bopindolol—ADRB2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00216	0.00216	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00212	0.00212	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00211	0.00211	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00211	0.00211	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.0021	0.0021	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.00208	0.00208	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00207	0.00207	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00207	0.00207	CbGpPWpGaD
Bopindolol—HTR1A—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	0.00204	0.00204	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00194	0.00194	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00193	0.00193	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.00193	0.00193	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.00191	0.00191	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.0019	0.0019	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00189	0.00189	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00186	0.00186	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00186	0.00186	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00186	0.00186	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00185	0.00185	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00182	0.00182	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00182	0.00182	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00182	0.00182	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00182	0.00182	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00178	0.00178	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00178	0.00178	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00178	0.00178	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00178	0.00178	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00176	0.00176	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.00175	0.00175	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00174	0.00174	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00174	0.00174	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.00174	0.00174	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00172	0.00172	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.00171	0.00171	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00168	0.00168	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00168	0.00168	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00165	0.00165	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00165	0.00165	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.00164	0.00164	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.00164	0.00164	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00164	0.00164	CbGpPWpGaD
Bopindolol—HTR1A—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	0.00164	0.00164	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00162	0.00162	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00162	0.00162	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00161	0.00161	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00158	0.00158	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00158	0.00158	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00158	0.00158	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00156	0.00156	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.00155	0.00155	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.00144	0.00144	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.00142	0.00142	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.00138	0.00138	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.00136	0.00136	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.00135	0.00135	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.00133	0.00133	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.00132	0.00132	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.0013	0.0013	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.0013	0.0013	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00126	0.00126	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.00125	0.00125	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00125	0.00125	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.00124	0.00124	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.00123	0.00123	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00123	0.00123	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.00122	0.00122	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.00122	0.00122	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00122	0.00122	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.00121	0.00121	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.00121	0.00121	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.0012	0.0012	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00119	0.00119	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.00118	0.00118	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.00115	0.00115	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.00113	0.00113	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.00113	0.00113	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.00112	0.00112	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.00111	0.00111	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.0011	0.0011	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.0011	0.0011	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.00108	0.00108	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.00104	0.00104	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.00101	0.00101	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000992	0.000992	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000976	0.000976	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000976	0.000976	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000954	0.000954	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000954	0.000954	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000933	0.000933	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000933	0.000933	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000932	0.000932	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000918	0.000918	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000904	0.000904	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.00084	0.00084	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000821	0.000821	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000742	0.000742	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000731	0.000731	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000726	0.000726	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.00072	0.00072	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000715	0.000715	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.00071	0.00071	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000704	0.000704	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000699	0.000699	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000689	0.000689	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000669	0.000669	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000654	0.000654	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000654	0.000654	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000651	0.000651	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000648	0.000648	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.00064	0.00064	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.00064	0.00064	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000626	0.000626	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000485	0.000485	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000483	0.000483	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000386	0.000386	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000384	0.000384	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000383	0.000383	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000378	0.000378	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000376	0.000376	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.00037	0.00037	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000368	0.000368	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000285	0.000285	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000227	0.000227	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000222	0.000222	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000217	0.000217	CbGpPWpGaD
